Supported by an educational grant from Pharming Healthcare, Inc.
Hereditary angioedema (HAE) is a rare, potentially life-threatening disease caused by deficiency or dysfunction of C1 esterase inhibitor (C1-INH), a part of the complement system involved in inhibition of swelling. Many of those most commonly reported symptoms of HAE (abdominal pain and swelling, swelling of extremities, and throat closure) overlap with conditions such as anaphylaxis, gastrointestinal disorders, acute surgical conditions, or acute pain conditions, making recognition of HAE very challenging. This, in turn, often leads to delays in diagnosis as well as inappropriate treatment. This program will utilize a case-based format to engage healthcare providers by linking discussion of the latest scientific data with its application in the clinical setting.
This educational initiative has been designed for allergists, emergency medicine physicians, nurse practitioners (NPs), and physician assistants (PAs) in specialty practice who are involved in the diagnosis and management of patients with HAE.
Upon completion of this educational activity, participants should be able to:
Differentiate key signs and symptoms of HAE from other common conditions and review the diagnostic tests in HAE
Identify key considerations in development of individualized treatment plans for patients with HAE
Conflict Of Interest Disclosure Policy
Integrity Continuing Education, Inc. requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any real or apparent COI they may have as related to the content of this activity. All identified COI are thoroughly vetted by Integrity Continuing Education, Inc. for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.
Faculty/planners reported their financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity under the Faculty heading below.
Joshua S. Jacobs, MD Medical Director of Clinical Research Allergy & Asthma Medical Group Walnut Creek, CA
Patima Tanapat, PhD, has no real or apparent conflicts of interest to disclose.
AMA PRA Category 1 Credit(s)TM
Integrity Continuing Education, Inc. is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education (CME) for physicians.
Integrity Continuing Education designates this enduring activity for a maximum of 1.00 AMA PRA Category 1 Credit(s)TM . Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Integrity Continuing Education, Inc. and Pharming Healthcare, Inc. do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of Integrity Continuing Education, Inc. and Pharming Healthcare, Inc. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
The information provided at this activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options of a specific patient's medical condition.
There are no fees for participating and receiving CME credit for this activity. During the period of December 6, 2017 through December 6, 2018, participants must:
Read the learning objectives and faculty disclosures
Complete the pre-test
Study the educational activity
Complete the post-test and the evaluation form
A statement of credit will be issued only upon receipt of a completed activity evaluation form and a completed post-test with a score of 70%.
For information about ACCME accreditation of this activity, please contact Integrity Continuing Education at (855) 835-4004 or firstname.lastname@example.org.